Midostaurin in Combination With Standard Chemotherapy for Treatment of Newly Diagnosed FMS-Like Tyrosine Kinase 3 (FLT3) Mutation–Positive Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028017747900
Abstract: Objective: To evaluate the efficacy and safety of midostaurin in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation in newly diagnosed FLT3-mutated acute myeloid leukemia (AML). Data Source: A literature search of PubMed… read more here.
Keywords: combination standard; midostaurin combination; newly diagnosed; diagnosed flt3 ... See more keywords